{"DataElement":{"publicId":"5527849","version":"1","preferredName":"Therapeutic Procedure Disease or Disorder Response Type","preferredDefinition":"A description of the disease response to therapy.","longName":"2935455v1.0:5544914v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2935455","version":"1","preferredName":"Therapeutic Procedure Disease or Disorder Response","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","longName":"THERP_DZ_RESP","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512834","version":"1","preferredName":"Therapeutic Procedure","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B89860A-B9D6-3798-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2729592","version":"1","preferredName":"Diseases and Disorders Response","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.:In medicine, an improvement related to treatment.","longName":"C2991:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"466FDD70-12AB-5C42-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-18","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-18","modifiedBy":"ONEDATA","dateModified":"2008-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71EAA652-0DFF-1177-E040-BB89AD4332DD","latestVersionIndicator":"Yes","beginDate":"2009-08-24","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-24","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5544914","version":"1","preferredName":"Disease Response Type","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._Something distinguishable as an identifiable class based on common qualities.","longName":"5544914v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Transformation to leukemia","valueDescription":"Transformation to Leukemia","ValueMeaning":{"publicId":"5583853","version":"1","preferredName":"Transformation to Leukemia","longName":"5583853","preferredDefinition":"Peripheral blood or bone marrow blast count of greater than or equal to 20 percent.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"429C8DA1-5877-2B0D-E053-F662850A65AC","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"429C8DA1-588F-2B0D-E053-F662850A65AC","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"ONEDATA","dateModified":"2016-12-01","deletedIndicator":"No"},{"value":"Splenic disease progression","valueDescription":"Splenic Disease Progression","ValueMeaning":{"publicId":"5544936","version":"1","preferredName":"Splenic Disease Progression","longName":"5544936","preferredDefinition":"Appearance of new splenomegaly palpable 5 cm below costal margin (BCM) or 100 percent increase in palpable distance BCM for baseline splenomegaly of 5 cm to 10 cm BCM, 50 percent increase in palpable distance BCM for baseline splenomegaly of 10 cm BCM, loss of spleen response, or symptomatic splenomegaly requiring splenectomy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDA816C-5CFE-7632-E053-F662850AF169","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FDA816C-5D17-7632-E053-F662850AF169","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"},{"value":"Non-splenic disease progression","valueDescription":"Non-Splenic Disease Progression","ValueMeaning":{"publicId":"5544937","version":"1","preferredName":"Non-Splenic Disease Progression","longName":"5544937","preferredDefinition":"Increase in blasts to 10 percent to 19 percent, intolerance to treatment due to hematologic/non-hematologic side effects, or new onset transfusion-requiring anemia.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDA816C-5D21-7632-E053-F662850AF169","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FDA816C-5D3A-7632-E053-F662850AF169","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"},{"value":"Clinical improvement","valueDescription":"Clinical Improvement","ValueMeaning":{"publicId":"5544938","version":"1","preferredName":"Clinical Improvement","longName":"5544938","preferredDefinition":"Defined as 50 percent improvement in\r\npalpable spleen length for spleen palpable by 10 cm, or complete resolution\r\nof splenomegaly for palpable spleen less than 10 cm.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDA816C-5D44-7632-E053-F662850AF169","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FDA816C-5D5D-7632-E053-F662850AF169","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"},{"value":"Stable disease","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FDA816C-5D67-7632-E053-F662850AF169","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2503462","version":"1","preferredName":"Response Type","preferredDefinition":"In medicine, an improvement related to treatment.:Type; a subdivision of a particular kind of thing.","longName":"C50995:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A0F51C2-CD5A-6923-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-02","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-02","modifiedBy":"ONEDATA","dateModified":"2006-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDA816C-5BC0-7632-E053-F662850AF169","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the disease response","type":"Preferred Question Text","description":"What was the disease response to therapy?","url":null,"context":"NHLBI"},{"name":"Response to therapy","type":"Alternate Question Text","description":"Response to therapy","url":null,"context":"NHLBI"},{"name":"Response to therapy","type":"Application Standard Question Text","description":"Response to therapy","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F40077C-9965-1E09-E053-F662850A334C","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-19","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}